APT Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	2,879	2,568	2,049	1,642	1,204	822.86
Other Revenue	17.61	16.41	16.62	8.49	11.55	5.82
Revenue	2,896	2,584	2,066	1,650	1,216	828.69
Revenue Growth	27.11%	25.08%	25.18%	35.71%	46.74%	72.85%
Cost of Revenue	800.69	707.39	579.89	486.14	354.04	259.08
Gross Profit	2,096	1,877	1,486	1,164	861.98	569.61
Selling, General & Admin	620.37	579.25	464.34	386.96	307.57	251.43
Research & Development	404.27	364.8	290.54	237.92	174.88	134.88
Other Operating Expenses	48.68	28.18	15.22	14.52	13.75	8.14
Operating Expenses	1,087	988.53	772.32	639.21	496.99	393.93
Operating Income	1,009	888.01	713.59	524.86	364.99	175.68
Interest Expense	-1.62	-1.46	-2.01	-3.69	-1.45	-1.63
Interest & Investment Income	41.05	30.73	25.23	27.74	23.94	13.26
Currency Exchange Gain (Loss)	-22.43	-5.3	2.83	2.66	1.17	-1
Other Non Operating Income (Expenses)	3.23	-0.83	-0.82	-0.04	-0.49	-0.5
EBT Excluding Unusual Items	1,029	911.16	738.83	551.53	388.16	185.81
Impairment of Goodwill	-	-	-	-3.84	-	-
Gain (Loss) on Sale of Investments	0.82	0.49	-16.7	-	0.34	21.72
Gain (Loss) on Sale of Assets	-1.26	-0.93	0.25	11.97	0.06	0.02
Asset Writedown	-1.72	-1.85	-0.83	-0.12	-10.68	-3.57
Other Unusual Items	33.54	27.43	24.42	36.83	17.25	17.58
Pretax Income	1,060	936.29	745.97	596.37	395.13	221.55
Income Tax Expense	143.46	128.55	87.8	74.24	54.98	26.7
Earnings From Continuing Operations	916.7	807.74	658.17	522.13	340.16	194.85
Minority Interest in Earnings	16.1	12.9	14.98	11.79	17.86	13.07
Net Income	932.79	820.64	673.15	533.92	358.02	207.92
Net Income to Common	932.79	820.64	673.15	533.92	358.02	207.92
Net Income Growth	23.43%	21.91%	26.08%	49.13%	72.19%	87.70%
Shares Outstanding (Basic)	141	141	140	140	140	137
Shares Outstanding (Diluted)	141	141	141	142	142	138
Shares Change	-0.26%	0.05%	-0.27%	-0.16%	2.99%	31.45%
EPS (Basic)	6.62	5.82	4.80	3.82	2.56	1.52
EPS (Diluted)	6.61	5.80	4.76	3.77	2.52	1.51
EPS Growth	23.74%	21.85%	26.41%	49.38%	67.20%	42.79%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	855.01	682.17	93.15	487.03	224.25	14.01
Free Cash Flow Per Share	6.06	4.82	0.66	3.44	1.58	0.10
Dividend Per Share	1.000	1.000	1.207	0.951	0.785	0.476
Dividend Growth	-17.14%	-17.14%	26.88%	21.20%	65.01%	100.00%
Gross Margin	72.36%	72.62%	71.93%	70.54%	70.88%	68.74%
Operating Margin	34.82%	34.37%	34.54%	31.81%	30.01%	21.20%
Profit Margin	32.20%	31.76%	32.58%	32.36%	29.44%	25.09%
Free Cash Flow Margin	29.52%	26.40%	4.51%	29.51%	18.44%	1.69%
EBITDA	1,117	988.48	790.98	580.9	405.69	203.49
EBITDA Margin	38.56%	38.26%	38.29%	35.20%	33.36%	24.56%
D&A For EBITDA	108.23	100.47	77.38	56.04	40.7	27.81
EBIT	1,009	888.01	713.59	524.86	364.99	175.68
EBIT Margin	34.82%	34.37%	34.54%	31.80%	30.01%	21.20%
Effective Tax Rate	13.53%	13.73%	11.77%	12.45%	13.91%	12.05%
Revenue as Reported	2,896	2,584	2,066	1,650	1,216	828.69